Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

T H Price

Showing results (81-90 of 96) with videos related to

Pageof 10
Sort By:
Lancet (London, England)|March 10, 1984
Absence of monoclonal-antibody-defined protein complex in boy with abnormal leucocyte functionP G Beatty, H D Ochs, J M Harlan, et al.
The American Journal of Medicine|August 26, 1996
Improving the efficacy of preoperative autologous blood donation in patients with low hematocrit: a randomized, double-blind, controlled trial of recombinant human erythropoietinT H Price, L T Goodnough, W R Vogler, et al.
Transfusion|January 1, 1996
The effect of recombinant human erythropoietin on the efficacy of autologous blood donation in patients with low hematocrits: a multicenter, randomized, double-blind, controlled trialT H Price, L T Goodnough, W R Vogler, et al.
The Journal of Applied Bacteriology|July 1, 1985
Collaborative study on the isolation of salmonella from artificially contaminated milk powderH J Beckers, F M van Leusden, D Roberts, et al.
Transfusion|January 1, 1994
A phase III trial of recombinant human erythropoietin therapy in nonanemic orthopedic patients subjected to aggressive removal of blood for autologous use: dose, response, toxicity, and efficacyL T Goodnough, T H Price, K D Friedman, et al.
British Journal of Haematology|August 1, 1994
Erythropoietin response to anaemia is not altered by surgery or recombinant human erythropoietin therapyL T Goodnough, T H Price, C A Parvin, et al.
Clinical Pharmacology and Therapeutics|October 3, 1998
Phase I study of a humanized anti-CD11/CD18 monoclonal antibody in multiple sclerosisJ D Bowen, S H Petersdorf, T L Richards, et al.
Blood|April 1, 1993
The effects of daily recombinant human granulocyte colony-stimulating factor administration on normal granulocyte donors undergoing leukapheresisW I Bensinger, T H Price, D C Dale, et al.
Blood|July 1, 1985
The role of neutrophil membrane glycoprotein GP-150 in neutrophil adherence to endothelium in vitroJ M Harlan, P D Killen, F M Senecal, et al.
The New England Journal of Medicine|October 26, 1989
Increased preoperative collection of autologous blood with recombinant human erythropoietin therapyL T Goodnough, S Rudnick, T H Price, et al.
Pageof 10

Showing results (81-90 of 96) with videos related to

Sort By:
Pageof 10
Lancet (London, England)|March 10, 1984
Absence of monoclonal-antibody-defined protein complex in boy with abnormal leucocyte functionP G Beatty, H D Ochs, J M Harlan, et al.
The American Journal of Medicine|August 26, 1996
Improving the efficacy of preoperative autologous blood donation in patients with low hematocrit: a randomized, double-blind, controlled trial of recombinant human erythropoietinT H Price, L T Goodnough, W R Vogler, et al.
Transfusion|January 1, 1996
The effect of recombinant human erythropoietin on the efficacy of autologous blood donation in patients with low hematocrits: a multicenter, randomized, double-blind, controlled trialT H Price, L T Goodnough, W R Vogler, et al.
The Journal of Applied Bacteriology|July 1, 1985
Collaborative study on the isolation of salmonella from artificially contaminated milk powderH J Beckers, F M van Leusden, D Roberts, et al.
Transfusion|January 1, 1994
A phase III trial of recombinant human erythropoietin therapy in nonanemic orthopedic patients subjected to aggressive removal of blood for autologous use: dose, response, toxicity, and efficacyL T Goodnough, T H Price, K D Friedman, et al.
British Journal of Haematology|August 1, 1994
Erythropoietin response to anaemia is not altered by surgery or recombinant human erythropoietin therapyL T Goodnough, T H Price, C A Parvin, et al.
Clinical Pharmacology and Therapeutics|October 3, 1998
Phase I study of a humanized anti-CD11/CD18 monoclonal antibody in multiple sclerosisJ D Bowen, S H Petersdorf, T L Richards, et al.
Blood|April 1, 1993
The effects of daily recombinant human granulocyte colony-stimulating factor administration on normal granulocyte donors undergoing leukapheresisW I Bensinger, T H Price, D C Dale, et al.
Blood|July 1, 1985
The role of neutrophil membrane glycoprotein GP-150 in neutrophil adherence to endothelium in vitroJ M Harlan, P D Killen, F M Senecal, et al.
The New England Journal of Medicine|October 26, 1989
Increased preoperative collection of autologous blood with recombinant human erythropoietin therapyL T Goodnough, S Rudnick, T H Price, et al.
Pageof 10